Early prediction of treatment response in advanced gliomas with (18)F-dopa positron-emission tomography

about

PET motion correction in context of integrated PET/MR: Current techniques, limitations, and future projections.18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.

P2860

Q47949954-BE45A3E7-CDBB-4032-9E4B-FFD33A0E7485 Q54135407-1A191C9F-D405-409C-BC73-D2AF70F6ED9A

P2860

Early prediction of treatment response in advanced gliomas with (18)F-dopa positron-emission tomography

Item

http://www.wikidata.org/entity/Q37577677

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Early prediction of treatment ...... a positron-emission tomography

@en

Early prediction of treatment response in advanced gliomas with

@nl

type

Item

label

Early prediction of treatment ...... a positron-emission tomography

@en

Early prediction of treatment response in advanced gliomas with

@nl

prefLabel

Early prediction of treatment ...... a positron-emission tomography

@en

Early prediction of treatment response in advanced gliomas with

@nl

P1476

Early prediction of treatment ...... a positron-emission tomography

@en

P2093

Craig Winter

http://www.w3.org/2001/XMLSchema#string

Jye Smith

http://www.w3.org/2001/XMLSchema#string

Michael Fay

http://www.w3.org/2001/XMLSchema#string

Olivier Salvado

http://www.w3.org/2001/XMLSchema#string

Paul Thomas

http://www.w3.org/2001/XMLSchema#string

Stephen Rose

http://www.w3.org/2001/XMLSchema#string

Stuart Crozier

http://www.w3.org/2001/XMLSchema#string

Yaniv Gal

http://www.w3.org/2001/XMLSchema#string

P2860

Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab.

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study.

P304

e172-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.21.1772

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260170726

http://www.w3.org/2001/XMLSchema#string

P698

24523617

http://www.w3.org/2001/XMLSchema#string

P932

3921044

http://www.w3.org/2001/XMLSchema#string

Early prediction of treatment response in advanced gliomas with (18)F-dopa positron-emission tomography

about

P2860

P2860

Early prediction of treatment response in advanced gliomas with (18)F-dopa positron-emission tomography

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932